Showing results (151-160 of 1,019) with videos related to
Sort By:
Pageof 102
Psychopharmacology Bulletin|August 1, 2008
Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010)Prakash S Masand, James Eudicone, Andrei Pikalov, et al.Expert Review of Neurotherapeutics|October 18, 2007
Fatigue as a core symptom in major depressive disorder: overview and the role of bupropionChi-Un Pae, Hyun-Kook Lim, Changsu Han, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2026
Brexpiprazole for the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease: Clinical PerspectivesHayeon Kim, Kyung Ho Lee, Changsu Han, et al.Journal of Clinical Psychopharmacology|December 13, 2016
Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-AnalysisSeoyoung Yoon, Sang Won Jeon, Young-Hoon Ko, et al.Psychosomatics|December 10, 2009
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatientsChangsu Han, Chi-Un Pae, Ashwin A Patkar, et al.Expert Opinion on Drug Safety|November 6, 2008
Paroxetine: safety and tolerability issuesDavid M Marks, Min-Hyeon Park, Byung-Joo Ham, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of SchizophreniaJung-Jin Kim, Chi-Un Pae, Changsu Han, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 2, 2019
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective StudyChangsu Han, Sheng-Min Wang, Won-Myong Bahk, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 24, 2010
Quetiapine XR: current status for the treatment of major depressive disorderChi-Un Pae, Manmohandeep Singh Sohi, Ho-Jun Seo, et al.Cancers|October 26, 2024
Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder CancerAnusha Gupta, Shiv Verma, Sanjay GuptaPageof 102